achievement 2008

8/14/2019 Achievement 2008

http://slidepdf.com/reader/full/achievement-2008 1/3

Aachen Resonance GmbHPauwelsstrasse 19, 52074 Aachen, Tel. +49-(0)241-97900905, Fax +49-(0)241-97900907, E-Mail: [email protected]

Aachen, Germany, 27.01.2009

Aachen Resonance congratulate Bioiasis for the achievements in2008

Communication:

Aachen Resonance announced that European medical device distributionspecialist BIOIASIS Plc, a public company listed in Sofia StockExchange (BUL:4OE) has received the award “No. 1 European Distributor2008” for the highest increment in sales for Aachen Resonance in Europe.

"We are pleased to honor Bioiasis "No. 1 European Distributor 2008" of Aachen Resonance,” said Dr. Alexander Ruebben, Director of AachenResonance. “Their sales grow with our products by more than 300% from thebeginning of 2008 to the end of 2008. Bioiasis confirmed their No. 1 positionand achieved the highest sales per nation in our European distributionnetwork. “

We congratulate Bioiasis to this success and thank Mr. Georgios Kissas,and the whole Bioiasis team for their outstanding performance and enduringcommitment to Aachen Resonance.

“We are really proud of this growth achievement and the fact that wehave received this award for the first time, even though we have only had the

south-east European distribution for Aachen Resonance since 2008,” saidGeorgios Kissas, president of Bioasis.

“ Aachen Resonance is a leader for innovative medical health care and this technology is strategic for the future success of Bioiasis. Their state of theart portfolio and our commitment towards Aachen Resonance will lead us tofurther strengthen both our positions on the European market. Our commonfuture really looks bright!”, Dr. Alexander Ruebben concluded.

Aachen Resonance Entwicklungsgesellschaft für magnetresonanz-kompatible Medizinprodukte mbH

Handelsregister: 8455 Aachen



Aachen Resonance is a leading European manufacturer of medical technology with aworldwide market presence. The company offers a complete line of products for treatment,

and advanced therapy support in vascular intervention, working in close collaboration with theUniversity of Technology in Aachen, Germany. Its main focus is developing new devices withimproved biocompatibility

The field of vascular intervention consists of balloon catheters, stents, drug elutingstents and drug eluting balloons for coronary and peripheral applications.

The company invests heavily in research and development, and is pursuing important,future-oriented approaches to cardiovascular therapy. Currently, Aachen Resonance maintainsthree headquarters in Europe for research and development and manufacturing.

Aachen Resonance is market leader in Europe for Drug eluting balloons.

Bioiasis Plc is an exclusive importer and distributor of medical materials and suppliesbased in Bulgaria. Bioiasis Plc is a public company listed in the Bulgarian Stock Exchange

under the code (BUL:4OE). The company operates in Bulgaria, Greece and Cyprus, Romania,Serbia and Montenegro, FYROM, Croatia through either direct sales or through well-chosenpartners.

Bioiasis Plc operates mainly but not limited to the fields of Interventional Cardiology,Interventional Radiology, Spine, Neurosurgery and Intraoperative Haemostasis. Bioiasis Plc isconsidered a market leader in the field of Interventional Cardiology bringing innovativetreatment options to developing markets.

Contact address:

Dr. Alexander Ruebben, MBAChairman of the Aachen Resonance

Aachen Resonance GmbHPauwelsstrasse 19D-52074 AachenGermany

Tel. 0049 241 97900905Fax. 0049 241 97900907www.aachen-resonance.com

Email: [email protected]

Contact Address:

Mr. Georgios KissasCEO

Bioiasis Plc83, Gueshevo Str.1330 SofiaBulgaria

Tel: +359 2 9207766Fax: +359 2 9207667www.bioiasis.com

Email:[email protected]



http://www.aachen-resonance.com/

mailto:[email protected]

http://www.bioiasis.com/


http://www.aachen-resonance.com/


http://www.bioiasis.com/


achievement 2008

Documents